Literature DB >> 6261006

Inheritance of susceptibility to the myeloproliferative sarcoma virus: effect of the Fv-2 locus and evidence for a myeloproliferative sarcoma virus resistance locus.

W Ostertag, T Odaka, F Smadja-Joffe, C Jasmin.   

Abstract

Myeloproliferative sarcoma virus (MPSV) causes a generalized stem cell leukemia with erythroid and myeloid hyperplasia in adult mice. MPSV also transforms fibroblasts. Mice congenic for the Fv-2 locus showed marked differences in susceptibility to MPSV according to the Fv-2 genotype. MPSV was injected into C57BL/6 Fvs and C57BL/6 Fv-2r mice congenic except for the Fv-2 locus. C57BL/6 mice with the Fvs genotype were much more susceptible to MPSV than were those with the Fvr genotype. Both DDD Fv-2r mice congenic with DDD Fv-2s mice except for the Fv-2 locus and DDD Fv-2s mice, however, were sensitive to spleen focus formation by MPSV. These data indicate that at least one additional resistance locus to MPSV is present in C57BL/6 mice but not in DDD mice. Both the Fv-2 locus and the putative MSPV resistance locus (loci) Mpsvr appear to be epistatic to either of the sensitivity loci. Fibroblast focus formation by MPSV was obtained well in C57BL/6 Fv-2r and C57BL/6 Fvs fibroblasts, indicating that the genes for MPSV resistance (Fv-2r and Mpsvr) were not operating in fibroblast cells. A model is proposed which may account for the differences in response of genetically different mice to MPSV and Friend spleen focus-forming virus.

Entities:  

Mesh:

Year:  1981        PMID: 6261006      PMCID: PMC171040     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  Friend strain of spleen focus-forming virus is a recombinant between ecotropic murine type C virus and the env gene region of xenotropic type C virus.

Authors:  D H Troxler; D Lowy; R Howk; H Young; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

2.  Inheritance of susceptibility to Friend mouse leukemia virus. X. Separate genetic control of two viruses in Friend virus preparation.

Authors:  T Odaka
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

3.  Synthesis of mouse haemoglobin and globin mRNA in leukaemic cell cultures.

Authors:  W Ostertag; H Melderis; G Steinheider; N Kluge; S Dube
Journal:  Nat New Biol       Date:  1972-10-25

4.  Inheritance of susceptibility to Friend mouse leukemia virus. 11. Spleen foci method applied to test the susceptibility of crossbred progeny between a sensitive and a resistant strain.

Authors:  T Odaka; T Yamamoto
Journal:  Jpn J Exp Med       Date:  1965-08

5.  Biological, pathological and physical characterization of a possible variant of a murine sarcoma virus (Moloney).

Authors:  M A Chirigos; D Scott; W Turner; K Perk
Journal:  Int J Cancer       Date:  1968-03-15       Impact factor: 7.396

6.  Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice.

Authors:  F Lilly
Journal:  J Natl Cancer Inst       Date:  1970-07       Impact factor: 13.506

7.  Study of a virus-induced myeloproliferative syndrome associated with tumor formation in mice.

Authors:  M C Le Bousse-Kerdiles; F Smadja-Joffe; B Klein; B Caillou; C Jasmin
Journal:  Eur J Cancer       Date:  1980-01       Impact factor: 9.162

8.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

9.  Fv-2 locus controls the proportion of erythropoietic progenitor cells (BFU-E) synthesizing DNA in normal mice.

Authors:  S Suzuki; A A Axelrad
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

10.  Inheritance of susceptibility to Friend mouse leukemia virus. V. Introduction of a gene responsible for susceptibility in the genetic complement of resistant mice.

Authors:  T Odaka
Journal:  J Virol       Date:  1969-06       Impact factor: 5.103

View more
  5 in total

1.  The myeloproliferative sarcoma virus causes transformation or erythroid progenitor cells in vitro.

Authors:  W D Hankins; T A Kost; I B Pragnell
Journal:  Mol Cell Biol       Date:  1982-02       Impact factor: 4.272

2.  Retroviral mutants efficiently expressed in embryonal carcinoma cells.

Authors:  T Franz; F Hilberg; B Seliger; C Stocking; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

3.  Action of temperature-sensitive mutants of myeloproliferative sarcoma virus suggests that fibroblast-transforming and hematopoietic transforming viral properties are related.

Authors:  W Ostertag; M Freshney; K Vehmeyer; C Jasmin; G Rutter
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

4.  Analysis of the myeloproliferative sarcoma virus genome: limited changes in the prototype lead to altered target cell specificity.

Authors:  I B Pragnell; A Fusco; C Arbuthnott; F Smadja-Joffe; B Klein; C Jasmin; W Ostertag
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

5.  Abrogation of the requirement for feeder cell interaction and T cell receptor stimulation of lymphocytes infected with retroviral vectors.

Authors:  C Laker; G Gräning; A Kelso; C Stocking; W Ostertag
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.